Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Sponsor: Emory University
This observational or N/A phase trial investigates Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma and is currently actively recruiting participants. Emory University leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Jun 2025 — Feb 2026 [monthly]
Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Mar 2023 — Mar 2024 [monthly]
Recruiting
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
Phase: PHASE1 → None
-
Sep 2021 — Dec 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Nov 2019 — Nov 2020 [monthly]
Recruiting PHASE1
-
Jun 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE1
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .